Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: A condition reversed by PKC activation

Journal of Leukocyte Biology

Volumn 80, Issue 6, 2006, Pages 1289-1297

  Cuschieri, Joseph ^a,b   Billigren, Jens ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD14; HSP70; Macrophage; PMA

Indexed keywords

CD14 ANTIGEN; CELL SURFACE RECEPTOR; ENDOTOXIN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LIPOPOLYSACCHARIDE; PROTEIN KINASE C; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPID RAFT; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNE TOLERANCE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE MICRODOMAINS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845508583     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0106053     Document Type: Article

References (44)

1. Bos, M. P., Tommassen, J. (2004) Biogenesis of the Gram-negative bacterial outer membrane. Curr. Opin. Microbiol. 7, 610-616.
2. Heumann, D., Lauener, R., Ryffel, B. (2003) The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds. J. Endotoxin Res. 9, 381-384.
3. Schutt, C. (1999) Cd14. Int. J. Biochem. Cell Biol. 31, 545-549.
4. Pugin, J., Kravchenko, V. V., Lee, J. D., Kline, L., Ulevitch, R. J., Tobias, P. S. (1998) Cell activation mediated by glycosylphosphatidylinositol- anchored or transmembrane forms of CD14. Infect. Immun. 66, 1174-1180.
5. Triantafilou, M., Miyake, K., Golenbock, D. T., Triantafilou, K. (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115, 2603-2611.
6. Triantafilou, M., Triantafilou, K. (2002) Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23, 301-304.
7. Jiang, Q., Akashi, S., Miyake, K., Petty, H. R. (2000) Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κ B. J. Immunol. 165, 3541-3544.
8. Cuschieri, J., Bulmus, V., Gourlay, D., Garcia, I., Hoffman, A., Stayton, P., Maier, R. V. (2004) Modulation of macrophage responsiveness to lipopolysaccharide by IRAK-1 manipulation. Shock 21, 182-188.
9. Hazeki, K., Masuda, N., Funami, K., Sukenobu, N., Matsumoto, M., Akira, S., Takeda, K., Seya, T., Hazeki, O. (2003) Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways. Eur. J. Immunol. 33, 740-747.
10. Weigand, M. A., Horner, C., Bardenheuer, H. J., Bouchon, A. (2004) The systemic inflammatory response syndrome. Best Pract. Res. Clin. Anaesthesiol. 18, 455-475.
11. Myrianthefs, P., Styliano, W., Venetsanou, K., Baltopoulos, G. (2004) LPS tolerance in septic ICU patients: laboratory and technical considerations. Surg. Infect. (Larchmt) 5, 63-64.
12. Lehner, M. D., Hartung, T. (2002) Endotoxin tolerance-mechanisms and beneficial effects in bacterial infection. Rev. Physiol. Biochem. Pharmacol. 144, 95-141.
13. West, M. A., Heagy, W. (2002) Endotoxin tolerance: a review. Crit. Care Med. 30, S64-S73.
14. Nomura, F., Akashi, S., Sakao, Y., Sato, S., Kawai, T., Matsumoto, M., Nakanishi, K., Kimoto, M., Miyake, K., Takeda, K., Akira, S. (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164, 3476-3479.
15. Fan, H., Cook, J. A. (2004) Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10, 71-84.
16. Medvedev, A. E., Vogel, S. N. (2003) Overexpression of CD14, TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. J. Endotoxin Res. 9, 60-64.
17. Dobrovolskaia, M. A., Vogel, S. N. (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4, 903-914.
18. Heagy, W., Hansen, C., Nieman, K., West, M. A. (2003) Evidence for a CD14- and serum-independent pathway in the induction of endotoxin-tolerance in human monocytes and THP-1 monocytic cells. Shock 19, 321-327.
19. Cuschieri, J., Umanskiy, K., Solomkin, J. (2004) PKC-ζ is essential for endotoxin-induced macrophage activation. J. Surg. Res. 121, 76-83.
20. West, M. A., LeMieur, T., Clair, L., Bellingham, J., Rodriguez, J. L. (1997) Protein kinase C regulates macrophage tumor necrosis factor secretion: direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery 122, 204-211.
21. Barie, P. S. (2004) Surviving sepsis. Surg. Infect. (Larchmt) 5, 1-2.
22. Heagy, W., Nieman, K., Hansen, C., Cohen, M., Danielson, D., West, M. A. (2003) Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg. Infect. (Larchmt) 4, 171-180.
23. Le Roux, P. (2004) An update on the pathophysiology of sepsis. SADJ 59, 163, 165.
24. Cobb, J. P., Buchman, T. G., Karl, I. E., Hotchkiss, R. S. (2000) Molecular biology of multiple organ dysfunction syndrome: injury, adaptation, and apoptosis. Surg. Infect. (Larchmt) 1, 207-215.
25. Zhang, D. M., Mao, B. L. (2003) Relationships between LPS-tolerance and TLR4 as well as its signaling pathway. Sheng Li Ke Xue Jin Zhan 34, 277-279.
26. Calvano, J. E., Agnese, D. M., Um, J. Y., Goshima, M., Singhal, R., Coyle, S. M., Reddell, M. T., Kumar, A., Calvano, S. E., Lowry, S. F. (2003) Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and Toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 20, 415-419.
27. Medvedev, A. E., Kopydlowski, K. M., Vogel, S. N. (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164, 5564-5574.
28. Medvedev, A. E., Henneke, P., Schromm, A., Lien, E., Ingalls, R., Fenton, M. J., Golenbock, D. T., Vogel, S. N. (2001) Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J. Immunol. 167, 2257-2267.
29. Cuschieri, J. (2004) Implications of lipid raft disintegration: enhanced anti-inflammatory macrophage phenotype. Surgery 136, 169-175.
30. Li, N., Shaw, A. R., Zhang, N., Mak, A., Li, L. (2004) Lipid raft proteomics: analysis of in-solution digest of sodium dodecyl sulfate-solubilized lipid raft proteins by liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry. Proteomics 4, 3156-3166.
31. Li, N., Mak, A., Richards, D. P., Naber, C., Keller, B. O., Li, L., Shaw, A. R. (2003) Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics 3, 536-548.
32. Kim, K. B., Kim, S. I., Choo, H. J., Kim, J. H., Ko, Y. G. (2004) Two-dimensional electrophoretic analysis reveals that lipid rafts are intact at physiological temperature. Proteomics 4, 3527-3535.
33. Baumruker, T., Csonga, R., Pursch, E., Pfeffer, A., Urtz, N., Sutton, S., Bofill-Cardona, E., Cooke, M., Prieschl, E. (2003) Activation of mast cells by incorporation of cholesterol into rafts. Int. Immunol. 15, 1207-1218.
34. de Gassart, A., Geminard, C., Fevrier, B., Raposo, G., Vidal, M. (2003) Lipid raft-associated protein sorting in exosomes. Blood 102, 4336-4344.
35. Young, R. M., Holowka, D., Baird, B. (2003) A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation. J. Biol. Chem. 278, 20746-20752.
36. Nebl, T., Pestonjamasp, K. N., Leszyk, J. D., Crowley, J. L., Oh, S. W., Luna, E. J. (2002) Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J. Biol. Chem. 277, 43399-43409.
37. Qu, X., Miah, S. M., Hatani, T., Okazaki, M., Hori-Tamura, N., Yamamura, H., Hotta, H., Sada, K. (2005) Selective inhibition of Fcε RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus. J. Biochem. (Tokyo) 137, 711-720.
38. Gulbins, E., Kolesnick, R. (2003) Raft ceramide in molecular medicine. Oncogene 22, 7070-7077.
39. Glebov, O. O., Nichols, B. J. (2004) Lipid raft proteins have a random distribution during localized activation of the T-cell receptor. Nat. Cell Biol. 6, 238-243.
40. Glebov, O. O., Nichols, B. J. (2004) Distribution of lipid raft markers in live cells. Biochem. Soc. Trans. 32, 673-675.
41. Fang, H., Pengal, R. A., Cao, X., Ganesan, L. P., Wewers, M. D., Marsh, C. B., Tridandapani, S. (2004) Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173, 360-366.
42. Beutler, B. (2004) SHIP, TGF-β, and endotoxin tolerance. Immunity 21, 134-135.
43. Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., Krystal, G. (2004) LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21, 227-239.
44. Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M., Krystal, G. (2002) SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-κ B activity. J. Immunol. 168, 4737-4746.